Previous Close | 6.00 |
Open | 6.18 |
Bid | 6.11 x N/A |
Ask | 6.16 x N/A |
Day's Range | 6.18 - 6.18 |
52 Week Range | 5.18 - 21.39 |
Volume | |
Avg. Volume | 2,604 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies HAMBURG, GERMANY / ACCESSWIRE / September 26, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, ...
J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region Just - Evotec Biologics' J.POD® technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and ...
WALTHAM, Mass., September 05, 2024--Evotec SE and X-Chem announces a collaboration agreement focused on accelerating early-stage drug discovery.